LC
BSX icon

Lavaca Capital’s Boston Scientific BSX Stock Holding History

Lavaca Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27K Hold
100
– – ﹤0.01% 332
2026
Q1 		$6.28K Hold
100
– – ﹤0.01% 269
2025
Q4 		$9.54K Hold
100
– – ﹤0.01% 257
2025
Q3 		$9.76K Hold
100
– – ﹤0.01% 240
2025
Q2 		$10.7K Buy
+100
New +$10.1K ﹤0.01% 237

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lavaca Capital's BSX Position: Q2 2026 in Review

Lavaca Capital held its Boston Scientific (BSX) position steady in Q2 2026 at 100 shares worth $4.27K. The position accounts for ﹤0.01% of the portfolio, ranked #332.

Lavaca Capital first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.7K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Lavaca Capital held 100 shares of Boston Scientific worth $4.27K as of Q2 2026.
  • Lavaca Capital left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Lavaca Capital's portfolio in Q2 2026, its #332 holding.
  • Lavaca Capital first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Lavaca Capital's Boston Scientific position peaked at $10.7K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.